Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor cells (CTCs) as liquid biopsies in patients with metastatic colorectal cancer versus other GI malignancies.
Authors
Pashtoon Murtaza Kasi
Weill Cornell Medicine, Englander Institute of Precision Medicine, New York Presbyterian Hospital, New York, NY;
Pashtoon Murtaza Kasi , Walla I Malkawi , Aliasger K Salem
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 192)
DOI
10.1200/JCO.2023.41.4_suppl.192
Abstract #
192
Poster Bd #
K14
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Prognostic value of integrated liquid biopsies in patients (pts) with metastatic urothelial cancer (mUC).
First Author: Charlotte Stahlfeld
Poster
2023 ASCO Gastrointestinal Cancers Symposium
FGFR2-amplified gastroesophageal adenocarcinoma is a distinct genomic class: Lessons learned from a liquid biopsy platform.
First Author: Bushra Shariff
Poster
2020 ASCO Virtual Scientific Program
Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis.
First Author: Steven Brad Maron
Poster
2019 ASCO Annual Meeting
Multimodality liquid biopsy for early monitoring and outcome prediction in first-line metastatic HER2-negative breast cancer: Final results of the prospective cohort from the French Breast Cancer InterGroup Unicancer (UCBG)— COMET study.
First Author: Jean-Yves Pierga